People in the News

Premium

Myriad Genetics said last week that it has elected Heiner Dreismann to its board of directors, increasing the company's board size to eight.

Dreismann, considered a pioneer in the early adoption of PCR, worked for Roche from 1985 to 2006, during which time he held several senior positions, including president and CEO of Roche Molecular Systems; head of global business development at Roche Diagnostics; and member of Roche's global diagnostic executive committee.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.